Anbio Biotechnology Additional Paid in Capital, Common Stock
Anbio Biotechnology (NNNN) had Additional Paid in Capital, Common Stock of $6.56 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-04-07
- 2025-12-31: Additional Paid in Capital, Common Stock $6.56M.
- 2024-12-31: Additional Paid in Capital, Common Stock $3.78K.
- 2023-12-31: Additional Paid in Capital, Common Stock $3.78K.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2025-12-31 | $6.56M 20-F · filed 2026-04-07 |
| 2024-12-31 | $3.78K 20-F · filed 2026-04-07 |
| 2023-12-31 | $3.78K 20-F · filed 2025-04-28 |